Cited by 443Antibiotic Resistance in BacteriaEscherichia coli research studiesUrinary Tract Infections Management

The DOI matches its Crossref record; 86 of the 89 references it cites were found in a registry or an index.

Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4

Peirano, Gisele, Pitout, Johann D.D.·2010·International Journal of Antimicrobial Agents

DOI 10.1016/j.ijantimicag.2009.11.003

Open this paper in CoChat — free account

Abstract

Since 2000, Escherichia coli producing CTX-M enzymes have emerged worldwide as important causes of community-onset urinary tract and bloodstream infections owing to extended-spectrum beta-lactamase (ESBL)-producing bacteria. Molecular epidemiological studies suggested that the sudden worldwide increase of CTX-M-15-producing E. coli was mainly due to a single clone (ST131) and that foreign travel to high-risk areas, such as the Indian subcontinent, might in part play a role in the spread of this clone across different continents. Empirical antibiotic coverage for these resistant organisms should be considered in community patients presenting with sepsis involving the urinary tract, especially if the patient recently travelled to a high-risk area. If this emerging public health threat is ignored, it is possible that the medical community may be forced, in the near future, to use carbapenems as the first choice for the empirical treatment of serious infections associated with urinary tract infections originating from the community.

Integrity signals

Registry

Crossref · 10.1016/j.ijantimicag.2009.11.003

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,203
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
Self-citation
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Resistance Plasmid Families in Enterobacteriaceae
Carattoli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-08 · Cited by 1,294
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,149
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D. N., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,121
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A. A., Strahilevitz, J., Jacoby, G. A., Macielag, M. J., Abbanat, D., Park, C. H., Bush, K., & Hooper, D. C. (2005) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,011
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Cantón, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J. A., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon‐Guibout, V., Demarty, R., Alonso, M. P., Caniça, M., Park, Y. J., Lavigne, J., Pitout, J. D. D., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 815
Self-citation

Show all 89 references

Sorted by citations

Items 201–300 of 441

Clonal relationship between human and avian ciprofloxacin-resistant Escherichia coli isolates in North-Eastern Algeria
Agabou, A., Lezzar, N., Ouchenane, Z., Khemissi, S., Satta, D., Sotto, A., Lavigne, J.-P., & Pantel, A. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2534-3 · Cited by 32
Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar
Naas, T., Cuzon, G., Robinson, A. L., Andrianirina, Z. Z., Imbert, P., Ratsima, E. H., Ranosiarisoa, Z. N., Nordmann, P., & Raymond, J. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1580-5 · Cited by 32
Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003–2014)
Arana, D. M., Alonso, M. R., & Alós, J.-I. (2017) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.03.020 · Cited by 32
Antimicrobial Resistance Patterns and Risk Factors Associated with ESBL-Producing and MDR Escherichia coli in Hospital and Environmental Settings in Lusaka, Zambia: Implications for One Health, Antimicrobial Stewardship and Surveillance Systems
Kasanga, M., Kwenda, G., Wu, J., Kasanga, M., Mwikisa, M. J., Chanda, R., Mupila, Z., Yankonde, B., Sikazwe, M., Mwila, E., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11081951 · Cited by 33
Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended‐spectrum β‐lactamases with focus on CTX‐M in a low‐endemic area in Sweden
Önnberg, A., Mölling, P., ZIMMERMANN, J., & Söderquist, B. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02730.x · Cited by 32
Detection of Escherichia coli Producing CTX-M-1-Group Extended-Spectrum β-Lactamases from Pigs in Aichi Prefecture, Japan, between 2015 and 2016
Norizuki, C., Kawamura, K., Wachino, J.-I., Suzuki, M., Nagano, N., Kondo, T., & Arakawa, Y. (2017) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2017.206 · Cited by 32
Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr
Kanamori, H., Yano, H., Tanouchi, A., Kakuta, R., Endo, S., Ichimura, S., Ogawa, M., Shimojima, M., Inomata, S., Ozawa, D., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.04.009 · Cited by 31
Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012
van der Steen, M., Leenstra, T., Kluytmans, J. A. J. W., van der Bij, A. K., & ISIS-AR study group (2015) · PLoS ONE · doi:10.1371/journal.pone.0138088 · Cited by 31
The Complex Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
Tal-Jasper, R., Coyle, J. R., Katz, D. E., & Marchaim, D. (2015) · Future Microbiology · doi:10.2217/fmb.15.16 · Cited by 30
High Prevalence of Cross-Resistance to Aminoglycosides in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates
Tsukamoto, N., Ohkoshi, Y., Okubo, T., Sato, T., Kuwahara, O., Fujii, N., Tamura, Y., & Yokota, S. (2013) · Chemotherapy · doi:10.1159/000361011 · Cited by 30
Detection of Extended-Spectrum β-Lactamase-Producing Escherichia coli Using Infrared Microscopy and Machine-Learning Algorithms
Sharaha, U., Rodriguez‐Diaz, E., Sagi, O., Riesenberg, K., Lapidot, I., Segal, Y., Bigio, I. J., Huleihel, M., & Salman, A. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05497 · Cited by 29
Genetic Environments of Plasmid-Mediated blaCTXM-15 Beta-Lactamase Gene in Enterobacteriaceae from Africa
Awosile, B., & Agbaje, M. (2021) · Microbiology Research · doi:10.3390/microbiolres12020026 · Cited by 29
Antimicrobial Resistance of Escherichia fergusonii Isolated from Broiler Chickens
Simmons, K., Islam, M. R., Rempel, H., Block, G., Topp, E., & Diarra, M. S. (2016) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-15-575 · Cited by 29
Characterization of Third-Generation Cephalosporin-Resistant Escherichia coli from Bloodstream Infections in Denmark
Hansen, F., Olsen, S. S., Heltberg, O., Justesen, U. S., Fuglsang-Damgaard, D., Knudsen, J. D., & Hammerum, A. M. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0157 · Cited by 29
Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, Mozambique
Guiral, E., Pons, M. J., Vubil, D. C., Marí-Almirall, M., Sigaúque, B., Soto, S. M., Alonso, P. L., Ruiz, J., Vilà, J., & Mandomando, I. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s153601 · Cited by 29
Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia
Alqasim, A., Jaffal, A. A., & Alyousef, A. A. (2019) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2019.09.020 · Cited by 29
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131
Kuroda, H., Yano, H., Hirakata, Y., Arai, K., Endo, S., Kanamori, H., Yamamoto, H. H., Ichimura, S., Ogawa, M., Shimojima, M., et al. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.06.011 · Cited by 28
The anti-virulence effect of cranberry active compound proanthocyanins (PACs) on expression of genes in the third-generation cephalosporin-resistant Escherichia coli CTX-M-15 associated with urinary tract infection
Samarasinghe, S., Reid, R., & AL-Bayati, M. A. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0637-9 · Cited by 28
Extensive Dissemination of Extended Spectrum β-Lactamase–Producing Enterobacteriaceae in a Dutch Nursing Home
Willemsen, I., Nelson, J., Hendriks, Y., Mulders, A., Verhoeff, S., Mulder, P. G. H., Roosendaal, R., van der Zwaluw, K., Verhulst, C., den Bergh, M. K.-V., et al. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2014.76 · Cited by 28
Prevalence and genetic characterization of cephalosporin-resistant Enterobacteriaceae among dogs and cats in an animal shelter
Umeda, K., Hase, A., Matsuo, M., Horimoto, T., & Ogasawara, J. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000933 · Cited by 28
Antibiotic Selection of Escherichia coli Sequence Type 131 in a Mouse Intestinal Colonization Model
Hertz, F. B., Løbner‐Olesen, A., & Frimodt‐Møller, N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03021-14 · Cited by 27
Prevalence of Fluoroquinolone-Resistant Escherichia coli O25:H4-ST131 (CTX-M-15-Nonproducing) Strains Isolated in Japan
Yokota, S., Sato, T., Okubo, T., Ohkoshi, Y., Okabayashi, T., Kuwahara, O., Tamura, Y., & Fujii, N. (2012) · Chemotherapy · doi:10.1159/000336129 · Cited by 27
Escherichia coli ST131 Producing Extended-Spectrum -Lactamases Plus VIM-1 Carbapenemase: Further Narrowing of Treatment Options
Mantengoli, E., Luzzaro, F., Pecile, P., Cecconi, D., Cavallo, A., Attala, L., Bartoloni, A., & Rossolini, G. M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq194 · Cited by 27
Lineage-Specific Methyltransferases Define the Methylome of the Globally Disseminated Escherichia coli ST131 Clone
Forde, B. M., Phan, M., Gawthorne, J. A., Ashcroft, M. M., Stanton-Cook, M. J., Sarkar, S., Peters, K. M., Chan, K., Chong, T. M., Yin, W., et al. (2015) · mBio · doi:10.1128/mbio.01602-15 · Cited by 27
The contributions of multidrug resistant clones to the success of pandemic extra-intestinal Pathogenic Escherichia coli
Pitout, J. D. D., Peirano, G., & DeVinney, R. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2184348 · Cited by 26
Self-citation
Diagnostic Potential of Monoclonal Antibodies Specific to the Unique O-Antigen of Multidrug-Resistant Epidemic Escherichia coli Clone ST131-O25b:H4
Szijártó, V., Łukasiewicz, J., Gozdziewicz, T. K., Magyarics, Z., Nagy, E., & Nagy, G. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00685-13 · Cited by 26
Phenotypic Microarrays Suggest Escherichia coli ST131 Is Not a Metabolically Distinct Lineage of Extra-Intestinal Pathogenic E. coli
Alqasim, A., Emes, R. D., Clark, G., Newcombe, J., Ragione, R. M. L., & McNally, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088374 · Cited by 26
Detection and molecular characterization of β-lactamase genes in clinical isolates of Gram-negative bacteria in Southern Ecuador
Delgado, D. Y. C., Toledo, Z., Astutillo, S. G. O., Jaramillo, A. P. A., & Ausili, A. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.07.001 · Cited by 26
Beta-lactamase resistance genes in Enterobacteriaceae from Nigeria
Awosile, B., Agbaje, M., Adebowale, O. O., Kehinde, O., & Omoshaba, E. (2022) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v11i1.1371 · Cited by 25
Implementation of Fourier transform infrared spectroscopy for the rapid typing of uropathogenic Escherichia coli
Dawson, S. E., Gibreel, T. M., Nicolaou, N., Alrabiah, H. K., Yun Xu, A., Goodacre, R., & Upton, M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2036-0 · Cited by 25
Extended-spectrum β-lactamases, transferable quinolone resistance, and virulotyping in extra-intestinal E. coli in Uruguay
Vignoli, R., García-Fulgueiras, V., Cordeiro, N. F., Bado, I., Seija, V., Aguerrebere, P., Laguna, G., Araújo, L., Bazet, C., Gutkind, G., et al. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6918 · Cited by 25
Comparative virulotyping of extended-spectrum cephalosporin-resistant E. coli isolated from broilers, humans on broiler farms and in the general population and UTI patients
van Hoek, A. H. A. M., Stalenhoef, J. E., van Duijkeren, E., & Franz, E. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.04.008 · Cited by 25
Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela
Guzmán, M., Salazar, E., Cordero, V., Castro, A., Villanueva, A., Rodulfo, H., & Donato, M. D. (2019) · Biomédica · doi:10.7705/biomedica.v39i2.4030 · Cited by 25
Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics
Downing, T. (2015) · Microorganisms · doi:10.3390/microorganisms3020236 · Cited by 26
Dynamics of antibiotic resistance with special reference to Shiga toxin-producingEscherichia coliinfections
Begum, J., Mir, N. A., Dev, K., & Khan, I. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.14034 · Cited by 24
Antibiotics in Phase II and III Clinical Trials
Coates, A. R. M., & Halls, G. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-28951-4_11 · Cited by 23
High prevalence of CTX-M belonging to ST410 and ST889 among ESBL producing E. coli isolates from waterfowl birds in China’s tropical island, Hainan
Yang, H. B., Rehman, M. U., Zhang, S., Yang, J., Li, Y., Gao, J., Gu, L., Wang, M., Jia, R., Chen, S., et al. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.03.008 · Cited by 23
A Comprehensive Account of Escherichia coli Sequence Type 131 in Wastewater Reveals an Abundance of Fluoroquinolone-Resistant Clade A Strains
Finn, T. J., Scriver, L., Lam, L., Duong, M. C., Peirano, G., Lynch, T., Dong, T., Pitout, J. D. D., & DeVinney, R. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01913-19 · Cited by 23
Self-citation
Tackling antimicrobial resistance in lower urinary tract infections: treatment options
Pitout, J. D. D., Chan, W. W. M., & Church, D. L. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1188004 · Cited by 23
Self-citation
Genomic epidemiology reveals geographical clustering of multidrug-resistant Escherichia coli ST131 associated with bacteraemia in Wales
White, R. T., Bull, M. J., Barker, C. R., Arnott, J. M., Wootton, M., Jones, L. S., Howe, R. A., Morgan, M., Ashcroft, M. M., Forde, B. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45608-1 · Cited by 22
Wastewater based genomic surveillance key to population level monitoring of AmpC/ESBL producing Escherichia coli
Al-Mustapha, A. I., Tiwari, A., Laukkanen‐Ninios, R., Lehto, K., Oikarinen, S., Lipponen, A., Pitkänen, T., Heikinheimo, A., WastPan Study Group, Heljanko, V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91516-9 · Cited by 22
CTX-M-Producing Escherichia coli: History, Molecular Epidemiology and Laboratory Detection
Peirano, G., Endimiani, A., & Pitout, J. D. D. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s553853 · Cited by 22
Self-citation
Susceptibility to Alternative Oral Antimicrobial Agents in Relation to Sequence Type ST131 Status and Coresistance Phenotype among Recent Escherichia coli Isolates from U.S. Veterans
Johnson, J. R., Drawz, S. M., Porter, S. B., & Kuskowski, M. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00650-13 · Cited by 22
Emergence of Fosfomycin Resistance by Plasmid-Mediated fos Genes in Uropathogenic ESBL-Producing E. coli Isolates in Mexico
Galindo-Méndez, M., Navarrete-Salazar, H., Baltazar-Jiménez, F., la Paz, E. M.-D., Sánchez-Mawcinitt, M. F., Gomez-Pardo, A., Garza‐González, E., Ponce‐de‐León, A., Franco‐Cendejas, R., Morfín‐Otero, R., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101383 · Cited by 22
Co-Harboring of Beta-Lactamases and mcr-1 Genes in Escherichia coli and Klebsiella pneumoniae from Healthy Carriers and Backyard Animals in Rural Communities in Ecuador
Bastidas‐Caldes, C., Cisneros-Vásquez, E., Zambrano, A., Mosquera-Maza, A., Calero‐Cáceres, W., Rey, J., Yamamoto, Y., Yamamoto, M., Calvopiña, M., & de Waard, J. H. (2023) · Antibiotics · doi:10.3390/antibiotics12050856 · Cited by 22
Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131
Cho, S. Y., Kang, C., Cha, M. K., Wi, Y. M., Ha, Y. E., Chung, D. R., Lee, N. Y., Peck, K. R., Song, J.-H., & on behalf of the Korean Network for Study on Infectious Diseases (KONSID) (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0261 · Cited by 22
Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: Comparison of pediatric and adult populations
Tsai, W.-L., Hung, C., Chen, H., Wang, J., Huang, I., Chiou, Y., Chen, Y.-S., Lee, S. S., Hung, W.-Y., & Cheng, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.08.005 · Cited by 22
Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-H30
Guachalla, L. M., Hartl, K., Varga, C., Stulik, L., Mirkina, I. I., Malafa, S., Nagy, E., Nagy, G., & Szijártó, V. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01428-17 · Cited by 22
Escherichia coli: An arduous voyage from commensal to Antibiotic-resistance
Chetri, S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107173 · Cited by 21
The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections
Adler, A., Katz, D. E., & Marchaim, D. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.06.003 · Cited by 21
Arrangements of Mobile Genetic Elements among Virotype E Subpopulation of Escherichia coli Sequence Type 131 Strains with High Antimicrobial Resistance and Virulence Gene Content
Pajand, O., Rahimi, H., Darabi, N., Roudi, S., Ghassemi, K., Aarestrup, F. M., & Leekitcharoenphon, P. (2021) · mSphere · doi:10.1128/msphere.00550-21 · Cited by 21
Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase–producing Escherichia coli causing bacteremia
Cha, M. K., Kang, C., Ys, K., Cho, S. Y., Ha, Y. E., Wi, Y. M., Chung, D. R., Peck, K. R., & Song, J. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.10.015 · Cited by 21
Concurrent emergence of multidrug resistance and heat resistance by CTX‐M‐15 ‐encoding conjugative plasmids in K lebsiella pneumoniae
Bojer, M. S., Hammerum, A. M., Jørgensen, S., Hansen, F., Olsen, S. S., Krogfelt, K. A., & Struve, C. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02885.x · Cited by 21
Escherichia coli-Mediated Impairment of Ureteric Contractility Is Uropathogenic E. coli Specific
Floyd, R. V., Upton, M., Hultgren, S. J., Wray, S., Burdyga, T. V., & Winstanley, C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis554 · Cited by 21
Dissemination of antibiotic resistance in the environment
Saima, S., Fiaz, M., Zafar, R., Ahmed, I., & Arshad, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818882-8.00006-1 · Cited by 21
The emergence of plasmid mediated quinolone resistance qnrA2 in extended spectrum β-lactamase producing Klebsiella pneumoniae in the Middle East
Vali, L., Dashti, A. A., Jadaon, M. M., & El‐Shazly, S. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0116-7 · Cited by 20
Escherichia colisequence type 131: epidemiology and challenges in treatment
Qureshi, Z. A., & Doi, Y. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.899901 · Cited by 20
Prevalence of CTX-M-Type and PER Extended-Spectrum β-Lactamases Among Klebsiella spp. Isolated From Clinical Specimens in the Teaching Hospital of Kashan, Iran
Amiri, A., Firoozeh, F., Moniri, R., & Zibaei, M. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.22260 · Cited by 20
Heat resistance in extended-spectrum beta-lactamase-producing Escherichia coli may favor environmental survival in a hospital setting
Boll, E. J., Frimodt-Møller, J., Olesen, B. R. S., Krogfelt, K. A., & Struve, C. (2016) · Research in Microbiology · doi:10.1016/j.resmic.2016.02.002 · Cited by 20
High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria
Williamson, D. A., Roberts, S., Smith, M., Heffernan, H., Tiong, A., Pope, C., & Freeman, J. T. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1380-1 · Cited by 20
Shift of CTX-M genotypes has determined the increased prevalence of extended-spectrum β-lactamase-producing Escherichia coli in south-western Sweden
Helldal, L., Karami, N., Florén-Johansson, K., Welinder‐Olsson, C., Moore, E. R. B., & Åhrén, C. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12086 · Cited by 19
Multidrug resistance and high virulence genotype in uropathogenic Escherichia coli due to diffusion of ST131 clonal group producing CTX-M-15: an emerging problem in a Tunisian hospital
Ferjani, S., Saïdani, M., Ennigrou, S., Hsairi, M., Slim, A. F., & Boubaker, I. B.-B. (2013) · Folia Microbiologica · doi:10.1007/s12223-013-0292-0 · Cited by 19
Of stewardship, motherhood and apple pie
Livermore, D. M. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.011 · Cited by 19
Distribución de grupos filogenéticos y factores de virulencia en cepas de Escherichia coli uropatógena productora de β-lactamasa CTX-M-15 aisladas de pacientes de la comunidad en Mérida, Venezuela
Millán, Y., Hernández, E., Millán, B., & Araque, M. (2014) · Revista Argentina de Microbiología · doi:10.1016/s0325-7541(14)70069-0 · Cited by 19
Mechanisms Involved in the Active Secretion of CTX-M-15 β-Lactamase by Pathogenic Escherichia coli ST131
Rangama, S., Lidbury, I. D. E. A., Holden, J. M., Borsetto, C., Murphy, A. R. J., Hawkey, P. M., & Wellington, E. M. H. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-21 · Cited by 18
Faecal carriage of extended-spectrumβ-lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France: a comparative epidemiological study
Fam, N., DEFASQUE, S., Bert, F., Leflon‐Guibout, V., Ray, A. A. E., El-Ghannam, M., Attia, M. E.-D., Omar, M. M., DESOUKI, D. G., Valla, D. C., et al. (2014) · Epidemiology and Infection · doi:10.1017/s0950268814001812 · Cited by 18
Insight into neonatal septicaemicEscherichia colifrom India with respect to phylogroups, serotypes, virulence, extended-spectrum-β-lactamases and association of ST131 clonal group
Roy, S., Datta, S., Das, P., Gaind, R., Pál, T., Tapader, R., Mukherjee, S., & Basu, S. (2015) · Epidemiology and Infection · doi:10.1017/s0950268815000539 · Cited by 18
The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in Kuwait
Dashti, A. A., Vali, L., El‐Shazly, S., & Jadaon, M. M. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0214-6 · Cited by 18
Characterization of bla CTX-M-27 /F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/ H 30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings
Matsuo, N., Nonogaki, R., Hayashi, M., Wachino, J.-I., Suzuki, M., Arakawa, Y., & Kawamura, K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00202-20 · Cited by 18
Rapid detection of B2-ST131 clonal group of extended-spectrum β-lactamase–producing Escherichia coli by matrix-assisted laser desorption ionization–time-of-flight mass spectrometry: discovery of a peculiar amino acid substitution in B2-ST131 clonal group
Nakamura, A., Komatsu, M., Kondo, A., Ohno, Y., Kohno, H., Nakamura, F., Matsuo, S., Ohnuma, K., Hatano, N., & Kawano, S. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.06.024 · Cited by 18
Multiresistant uropathogenic extended-spectrum β-lactamase (ESBL)-producing Escherichia coli are susceptible to the carbon monoxide releasing molecule-2 (CORM-2)
Bang, C. S., Kruse, R. L., Demirel, I., Önnberg, A., Söderquist, B., & Persson, K. (2013) · Microbial Pathogenesis · doi:10.1016/j.micpath.2013.12.003 · Cited by 18
Prevalence of Extended Spectrumβ-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates ofPseudomonasfrom Patients of Khyber Pakhtunkhwa, Pakistan
Ahmad, M., Hassan, M., Khalid, A., Tariq, I., Asad, M. H. H. B., Samad, A., Mahmood, Q., & Murtaza, G. (2016) · BioMed Research International · doi:10.1155/2016/6068429 · Cited by 17
Prevalence of CTX-M-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli B2-O25-ST131 H30 R Among Residents in Nonacute Care Facilities in Japan
Kawamura, K., Hayashi, K., Matsuo, N., Kitaoka, K., Kimura, K., Wachino, J., Kondo, T., Iinuma, Y., Murakami, N., Fujimoto, S., et al. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0068 · Cited by 17
Characterization of Human Uropathogenic ESBL-Producing Escherichia coli in the Czech Republic: Spread of CTX-M-27-Producing Strains in a University Hospital
Micenková, L., Šišková, P., Bosák, J., Jamborová, I., Černohorská, L., & Šmajs, D. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0013 · Cited by 16
The cnf1 gene is associated with an expanding Escherichia coli ST131 H 30Rx/C2 subclade and confers a competitive advantage for gut colonization
Tsoumtsa, L. L., Landraud, L., Petracchini, S., Descorps‐Declère, S., Perthame, É., Nahori, M., Finn, L. R., Ingersoll, M. A., Patiño‐Navarrete, R., Glaser, P., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2121577 · Cited by 16
Molecular epidemiology, plasmid analysis, virulence, and resistance of Escherichia coli isolated from neonatal intensive care units in Poland
Chmielarczyk, A., Pobiega, M., Wójkowska‐Mach, J., Romaniszyn, D., Adamski, P., Heczko, P. B., & Bulanda, M. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.04.016 · Cited by 16
The role of Sequence Type (ST) 131 in adult community-onset non-ESBL-producing Escherichia colibacteraemia
Wu, Y.-H., Cheng, M., Lai, C.-H., Lin, H.-H., Hung, C., & Wang, J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0579-z · Cited by 16
Prevalence and molecular characteristics of multi-resistant Escherichia coli in wild birds
Merkevičienė, L., Klimienė, I., Šiugždinienė, R., Virgailis, M., Mockeliūnas, R., & Ružauskas, M. (2018) · Acta Veterinaria Brno · doi:10.2754/avb201887010009 · Cited by 16
Antibacterial Activity of Medicinal Plants against Uropathogenic Escherichia coli
Marouf, R., Arsène, M. M. J., Ermolaev, A. V., Podoprigora, I. V., Smirnova, I. P., Yashina, N. V., Zhigunova, A. V., & Aliya, V. M. (2022) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_124_21 · Cited by 16
Prevalence of CTX-M-Type Extended-Spectrum β-Lactamases in Escherichia coli Strains Isolated in Poultry Farms
Abreu, R., Castro, B., Espigares, E., Rodríguez‐Alvarez, C., Lecuona, M., Moreno, E., Espigares, M., & Arias, Á. (2014) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2014.1796 · Cited by 16
Emergence and Spread of Antimicrobial-Resistant Pathogens in an Era of Globalization
Senok, A. C., Botta, G. A., & Soge, O. O. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/286703 · Cited by 16
Predominance of IncL/M and IncF plasmid types among CTX-M-ESBL-producingEscherichia coliandKlebsiella pneumoniaein Bulgarian hospitals
Markovska, R. D., Schneider, I., Ivanova, D., Mitov, I., & Bauernfeind, A. (2013) · Apmis · doi:10.1111/apm.12204 · Cited by 15
Genetic and phenotypic characterisation of Escherichia coli producing cefotaximase-type extended-spectrum β-lactamases: first evidence of the ST131 clone in cats with urinary infections in Italy
Nebbia, P., Tramuta, C., Odore, R., Nucera, D. M., Zanatta, R., & Robino, P. (2014) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x14527103 · Cited by 15
Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology
holt, A. F. V. I. ’., Wattel, A. A., Boers, S. A., Jansen, R., Hays, J. P., Goessens, W. H. F., & Vos, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160156 · Cited by 15
Changes in pathogen spectrum and antimicrobial resistance development in the time‐course of acute necrotizing pancreatitis
Würstle, S. M., Hapfelmeier, A., Wöhrle, C., Dichtl, K., Lahmer, T., Rasch, S., Huber, W., Weber, A., Algül, H., Spinner, C. D., et al. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14748 · Cited by 15
Genomic and Proteomic Characterization of the Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Strain CCUG 73778: A Virulent, Nosocomial Outbreak Strain
Jaén‐Luchoro, D., Busquets, A., Karlsson, R., Salvà‐Serra, F., Åhrén, C., Karami, N., & Moore, E. R. B. (2020) · Microorganisms · doi:10.3390/microorganisms8060893 · Cited by 15
[Prevalence of beta-lactamase CTX-M-15 in phylogenetic groups of uropathogenic Escherichia coli isolated from patients in the community of Merida, Venezuela].
Hernández, E., Araque, M., Millán, Y., Millán, B., & Vielma, S. A. (2014) · PubMed · Cited by 14
Risk Factors for Extended Spectrum β-Lactamase-Producing Escherichia coli versus Susceptible E. coli in Surgical Site Infections among Cancer Patients in Mexico
Montes, C. V., Vilar-Compte, D., Velázquez, C., Golzarri, M. F., Cornejo‐Juárez, P., & Larson, E. (2014) · Surgical Infections · doi:10.1089/sur.2013.189 · Cited by 14
Complete Genome Sequence of a CTX-M-15-Producing Escherichia coli Strain from the H 30Rx Subclone of Sequence Type 131 from a Patient with Recurrent Urinary Tract Infections, Closely Related to a Lethal Urosepsis Isolate from the Patient's Sister
Johnson, T. J., Aziz, M., Liu, C. M., Sokurenko, E. V., Kisiela, D., Paul, S., Andersen, P. S., Johnson, J. R., & Price, L. B. (2016) · Genome Announcements · doi:10.1128/genomea.00334-16 · Cited by 14
High prevalence of sequence type 131 isolates producing CTX-M-15 among extended-spectrum β-lactamase-producing Escherichia coli strains in northeast Iran
Moghanni, M., Ghazvini, K., Farsiani, H., Namaei, M. H., Derakhshan, M., Youssefi, M., Maragheh, A., & Jamehdar, S. A. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.05.016 · Cited by 14
Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study
Nagarjuna, D., Mittal, G., Dhanda, R. S., Gaind, R., & Yadav, M. C. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0444-8 · Cited by 14
No evidence of carbapenemase-producing Enterobacteriaceae in stool samples of 1,544 asylum seekers arriving in Rhineland-Palatinate, Germany, April 2016 to March, 2017
Ehlkes, L., Pfeifer, Y., Werner, G., Ignatius, R., Vogt, M., Eckmanns, T., Zanger, P., & Walter, J. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.8.1800030 · Cited by 14
Prevalence of O25b-ST131 clone amongEscherichia colistrains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases
Giedraitienė, A., Vitkauskienė, A., Pavilonis, A., Patamsytė, V., Genel, N., Decré, D., & Arlet, G. (2016) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2016.1221531 · Cited by 14
Infections bactériennes néonatales précoces
Chemsi, M., & Benomar, S. (2014) · Journal de Pédiatrie et de Puériculture · doi:10.1016/j.jpp.2014.10.005 · Cited by 13
Phylogenetic association of fluoroquinolone and cephalosporin resistance of D-O1-ST648 Escherichia coli carrying bla CMY-2 from faecal samples of dogs in Japan
Sato, T., Yokota, S., Okubo, T., Usui, M., Fujii, N., & Tamura, Y. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.054676-0 · Cited by 13
Multidrug Resistance Dissemination in Escherichia coli Isolated from Wild Animals: Bacterial Clones and Plasmid Complicity
Sabença, C., Igrejas, G., Poeta, P. A. C. Q. D., Robin, F., Bonnet, R., & Beyrouthy, R. (2021) · Microbiology Research · doi:10.3390/microbiolres12010009 · Cited by 13
Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended‐spectrum β‐lactamases
Starlander, G., Yin, H., Edquist, P. J., & Melhus, Å. (2013) · Apmis · doi:10.1111/apm.12102 · Cited by 13
Phenotypic and molecular characterization of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli isolates in Shiraz, Iran
Zamani, K., Emami, A., Bazargani, A., & Moattari, A. (2015) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0315-2014 · Cited by 13
Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales vs Carbapenems: A Retrospective Study
Kashihara, E., Sada, R. M., Tsugihashi, Y., Obayashi, H., Nakamura, A., Abe, N., Miyake, H., & Akebo, H. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad502 · Cited by 12
CTX-M from community-acquired urinary tract infections in Algeria
Gharout-Sait, A. (2012) · African Journal of Microbiology Research · doi:10.5897/ajmr11.1478 · Cited by 12

Authors: Peirano, G., & Pitout, J. D. D.
Affiliations: University of Calgary (CA)
ORCID: Pitout, Johann D.D.
Venue: International Journal of Antimicrobial Agents
Publisher: Elsevier BV
Published: 2010-04
Volume: 35
Issue: 4
Pages: 316-321
ISSN: 0924-8579 (ISSN-L)
DOI: 10.1016/j.ijantimicag.2009.11.003
OpenAlex: W2087341525
Cited by: 443
References: 89
Citations by year: 2026: 8 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 14 · 2021: 15 · 2020: 18 · 2019: 28 · 2018: 20 · 2017: 18 · 2016: 39 · 2015: 35 · 2014: 49 · 2013: 52 · 2012: 56
FWCI: 2.40
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: International Journal of Antimicrobial Agents (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Keywords: Escherichia coli, CTX-M, ST131, extended-spectrum beta-lactamase, molecular epidemiology, antimicrobial resistance, urinary tract infection, bloodstream infection, sepsis, international travel, Indian subcontinent, empirical antibiotic therapy, carbapenems
MeSH terms: Anti-Bacterial Agents, beta-Lactamases, Disease Outbreaks, Escherichia coli, Escherichia coli Infections, Humans, Travel, Urinary Tract Infections, Bacterial Typing Techniques, Bacteremia, Molecular Epidemiology, Escherichia coli Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks